A Study to Learn About How Well BAY 3401016 Works in Adults With Alport Syndrome

Clinical trial NCT07211685 · RECRUITING

Trial details

NCT number: NCT07211685
Sponsor: Bayer
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Alport Syndrome

Start date: 2025-11-19
Primary completion: 2028-07-27
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.